MTOR and myeloproliferative disorder: In addition to the observation, of ours and Huang et al. [54], that downstream components of the mTOR pathway in MPN cells are inhibited by PIM inhibitors, we also observed a decrease in phosphorylation of BAD at Ser-112, a known phosphorylation target of PIM.